Chapter 8: Target Organ and Target System Toxicity

Spielmann H. , Bochkov N.P. , Costa L. , Gribaldo L. , Guillouzo A. , Heindel J.J. , Karol M. , Parchment R. , Pfaller W. , Peraita P.P. , & Zacharewski T. (1998). Alternative testing methodologies for organ toxicity. 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC). Environmental Health Perspectives 106, Suppl. 2, 427–439.

Miles A.T. , Hawksworth G.M. , Beattie J.H. , & Rodilla V. (2000). Induction, regulation, degradation, and biological significance of mammalian met-allothioneins. Critical Reviews in Biochemistry and Molecular Biology 35, 35–70.

Combes R.D. (1999). Summary of discussion: in vitro models for investigation of chronic toxicity and reversibility. Toxicology in Vitro 13, 853–857.

Minuth W.W. , Dermietzel R. , Kloth S. , & Hennerkes B. (1992). A new method culturing renal cells under permanent superfusion and producing a luminal-basal medium gradient. Kidney International 41, 215–219.

Hopfer U. , Jacobberger J.W. , Grunet D.C. , Eckert R.L. , Jat P.S. , & Whisett J.A. (1996). Immortalization of epithelial cells. American Journal of Physiology 270, C1–C11.

Schmuck G. , & Schlüter G. (1996). An in vitro model for toxicological investigations of environmental neurotoxins in primary neuronal cell cultures. Toxicology and Industrial Health 12, 683–696.

Houy S. (1998). Primary rat hepatocytes in collagen-sandwich configuration. Characterization and first application as a toxicological in vitro tool. PhD thesis. Department of Chemistry, University of Kaiserslautern, Germany.

Hanley A.B. , McBride J. , Oehlschlager S. , & Opara E. (1999). In vitro models for investigation of chronic toxicity and reversibility: use of a flow cell bioreactor as a chronic toxicity model system. Toxicology in Vitro 13, 847–851.

Pfaller W. , Felder E. , Koppelstaetter C. , Abbot S.E. , & Westwick J. (1999). Epiflow: a new cell culture system utilising continous medium exchange and continuous supply with gases. ATLA 27, Special Issue, 309.

Scheers E.M. , Ekwall B.A. , & Dierickx P.J. (2001). In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data. Toxicology in Vitro 15, 153–161.

Pfaller W. , Balls M. , Clothier R. , Dierickx P. , Ekwall B. , Hanley B.A. , Hartung T. , Prieto P. , Ryan M.P. , Schmuck G. , Sladowski D. , Vericat J.A. , Wendel A. , Wolf A. , & Zimmer J. (2001). Novel advanced in vitro methods for long-term toxicity testing. The report and recommendations of ECVAM workshop 45. ATLA 29, 393–426.

Hawksworth G.M. , Bach P.H. , Nagelkerke J.F. , Dekant W. , Diezi J.E. , Harpur E. , Lock E.A. , MacDonald C. , Morin P-P. , Pfaller W. , Rutten A.A.J.J.L. , Ryan M.P. , Toutain H.J. , & Trevisan A. (1995). Nephrotoxicity testing in vitro. The report and recommendations of ECVAM workshop 10. ATLA 23, 713–727.

Morin J-P. , De Broe M.E. , Pfaller W. , & Schmuck G. (1997). Nephrotoxicity testing in vitro: the current situation. ECVAM nephrotoxicity task force report 1. ATLA 25, 497–503.

Pfaller W. , & Gstraunthaler G. (1998). Nephrotoxicity testing in vitro: what we know and what we need to know. Environmental Health Perspectives 106, 559–569.

Gstraunthaler G. (1988). Epithelial cells in tissue culture. Renal Physiology and Biochemistry 11, 1–42.

Pfaller W. , & Troppmair E. (2000). Renal transepithelial resistance (TER) and paracellular permeability (PCP) are reliable endpoints to screen for nephrotoxicity. In Progress in the Reduction, Refinement and Replacement of Animal Experiments (ed. Balls M. , van Zeller A-M. , & Halder M.E. ), pp. 291–304. Amsterdam, The Netherlands: Elsevier.

Steinmassl D. , Pfaller W. , Gstraunthaler G. , & Hoffmann W. (1995). LLC-PK1 cells as a model for in vitro assessment of proximal tubular nephrotoxicity. In Vitro Cellular and Developmental Biology 31, 94–106.

OECD (1995). OECD Guidelines for the Testing of Chemicals No. 418: Delayed Neurotoxicity of Organophosphorous Substances Following Acute Exposure, 8 pp. Paris, France: Organisation for Economic Cooperation and Development.

OECD (1995). OECD Guidelines for the Testing of Chemicals No. 419: Delayed Neurotoxicity of Organophosphorous Substances — 28-day Repeated Dose Study, 7 pp. Paris, France: Organisation for Economic Cooperation and Development.

OECD (1997). OECD Guidelines for the Testing of Chemicals No. 424: Neurotoxicity Study in Rodents, 10 pp. Paris, France: Organisation for Economic Cooperation and Development.

Atterwill C.K. , Bruinink A. , Drejer J. , Duarte E. , Abdulla E.M. , Meredith C. , Nicotera P. , Regan C. , Rodríguez-Farré E. , Simpson M.G. , Smith R. , Veronesi B. , Vijverberg H. , Walum E. , & Williams D.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop report 3. ATLA 22, 350–362.

Costa L. (1998). Neurotoxicity testing: a discussion of in vitro alternatives. Environmental Health Perspectives 106, Suppl. 2, 505–510.

Abdulla E.M. , Atterwill C. , & Campbell I.C. (1995). Workshop on in vitro neurotoxicity testing: the obstacles, the way forward. Clinical and Experimental Pharmacology and Physiology 22, 277–280.

Veronesi B. (1992). In vitro screening batteries for neurotoxicants. Neurotoxicology 13, 185–196.

Walum E. , Balls M. , Bianchi V. , Blaauboer B. , Bolcsfoldi G. , Guillouzo A. , Moore G.A. , Odland L. , Reinhardt C. , & Spielmann H. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 20, 406–428.

Abdulla E.M. , & Campbell I.C. (1993). In vitro tests of neurotoxicity. Journal of Pharmacological and Toxicological Methods 29, 69–75.

Williams S.P. , O'Brien S. , Whitmore K. , Purcell W.M. , Cookson M.R. , Mead C. , Pentreath V.W. , & Atterwill C.K. (1996). An in vitro neurotoxicity testing scheme: evaluation of cytotoxicity determinations in neural and non-neural cells. In Vitro Toxicology 9, 83–92.

Balls M. , & Walum E. (1999). Towards the acceptance of in vitro neurotoxicity tests. In Neurotoxicology In Vitro (ed. Pentreath V.W. ), pp. 269–283. London, UK: Taylor & Francis.

Blaauboer B.J. , Barratt M.D. , & Houston J.B. (1999). The integrated use of alternative methods in toxicological risk evalutaion. ECVAM integrated testing strategies task force report 1. ATLA 27, 229–237.

Fielder R.J. , Atterwill C.K. , Anderson D. , Boobis A.R. , Botham P. , Chamberlain M. , Combes R. , Duffy P. , Lewis R.W. , Lumley C.E. , Kimber I. , & Newall D.R. (1997). BTS working party report on in vitro toxicology. Human and Experimental Toxicology 16, S1–S40.

Pentreath V.W. ed. (1999). Neurotoxicology In Vitro, 291 pp. London, UK: Taylor & Francis.

Williams S.P. , Davenport-Jones J. , Egan C. , O'Hare S. , Cookson M. , McClean R. , Garle M.J. , Pentreath V. , & Atterwill C.K. (1994). Phase 1 of an in vitro neurotoxicological prevalidation trial. Toxicology in Vitro 8, 799–802.

Weiss M.T. , & Sawyer T.W. (1993). Cytotoxicity of the MEIC test chemicals in primary neurone cultures. Toxicology in Vitro 7, 653–667.

Xie K. , & Harvey A.L. (1993). Evaluation of nerve cell toxicity in vitro by electrophysiological and biochemical methods. Toxicology in Vitro 7, 275–279.

Henschler D. , Schmuch G. , van Aerssen M. , & Schiffmann D. (1992). The inhibitory effect of neuropathic organophosphate esters on neurite outgrowth in cell cultures: a basis for screening for delayed neurotoxicity. Toxicology in Vitro 6, 327–335.

Forsby A. , Pilli F. , Bianchi V. , & Walum E. (1995). Determination of critical cellular neurotoxic concentrations in human neuroblastoma cell cultures. ATLA 23, 800–811.

Atterwill C.K. , & Purcell W.M. (1999). Brain spheroid and other organotypic culture systems in in vitro neurotoxicology. In Neurotoxicology In Vitro (ed. Pentreath V.W. ), pp. 213–238. London, UK: Taylor & Francis.

Monnet-Tschudi F. , Zurich M-G. , & Honegger P. (1997). Aggregate cell cultures for neurotoxicity testing: the importance of cell–cell interactions. In Animal Alternatives, Welfare and Ethics. (ed. van Zutphen L.F.M. , & Balls M. ), pp. 641–649. Amsterdam, The Netherlands: Elsevier.

Honegger P. , & Schilter B. (1992). Serum-free aggregate cultures of foetal rat brain and liver cells: methodology and some practical applications in neu-rotoxicology. In The Brain in Bits and Pieces: In Vitro Techniques in Neurobiology, Neuropharm-acology and Neurotoxicology (ed. Zbinden G. ), pp. 51–79. Zollikon, Switzerland: MTC Verlag.

Kucera P. , Cano E. , Honegger P. , Zijlstra J.A. , & Schmid B. (1993). Validation of whole chick embryo cultures, whole rat embryo cultures and aggregating embryonic brain cell cultures using six pairs of coded compounds. Toxicology in Vitro 7, 785–798.

Zurich M.G. , Honegger P. , Schilter B. , Costa L.G. , & Monnet-Tschudi F. (2000). Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. Neurotoxicology 21, 599–605.

Svendsen C.N. , Borg M.G. , Armstrong R.J.E. , Rosser A.E. , Chandran S. , Ostenfeld T. , & Caldwell M.A. (1998). A new method for the rapid and long term growth of human neural precursor cells. Journal of Neuroscience Methods 85, 141–152.

Stingele S. (2000). Development of genetically engineered neuronal cell lines for pharmacotoxicological studies. PhD thesis. University of Konstanz, Germany.

Stingele S. , Coecke S. , Nicotera P. , & Balls M. (1999). EC Patent filed 27th of August 1999 on Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing. Patent No. 99402139.2–2106/ International No. PCT/EP00/08223. Rijswijk, The Netherlands: European Patent Office.